Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer-Reference-Cited by-同舟云学术

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer

Published:2021-02-09 Issue:6 Volume:12 Page:949-957
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Kanai Osamu¹^ORCID,Ito Takanori¹,Saito Zentaro¹,Yamamoto Yuki²,Fujita Kohei¹^ORCID,Okamura Misato¹,Hashimoto Masayuki³,Nakatani Koichi¹,Sawai Satoru³,Mio Tadashi¹

Affiliation:

1. Division of Respiratory Medicine National Hospital Organization Kyoto Medical Center Kyoto Japan

2. Department of Drug Discovery for Lung Diseases Graduate School of Medicine, Kyoto University Kyoto Japan

3. Department of Thoracic Surgery National Hospital Organization Kyoto Medical Center Kyoto Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13845

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

3. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

4. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of systemic immune-inflammation index/albumin ratio for immunotherapy-treated patients receiving opioids;PLOS ONE;2024-06-27

2. Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy;Rheumatic Disease Clinics of North America;2024-05

3. Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma;Thoracic Cancer;2024-04-15

4. Identifying Genetic Signatures Associated with Oncogene-Induced Replication Stress in Osteosarcoma and Screening for Potential Targeted Drugs;Biochemical Genetics;2023-09-06

5. Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness;Frontiers in Immunology;2023-04-26